BEIJING, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a strategic cooperation agreement with the Clinical Sleep Medicine Center of the Air Force General Hospital (the "Hospital") to fully cooperate on sleep-related clinical research studies, sleep disease diagnosis and treatment, technology and equipment clinical tests, as well as public education and a sleep disorder awareness campaign. Established in October 1956 in Beijing, the Air Force General Hospital is one of the leading hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems as well.
Dr. He Gao, Director of the Sleep Center of the Air Force General Hospital, commented: "While thousands of our patients have benefitted from Dehaier's innovative wearable sleep respiratory solution systems over the past several months, we look forward to full cooperation with Dehaier to accelerate our efforts in advancing sleep disorder clinical research, diagnostic system development and data analytics as well as jointly promoting awareness of sleep disorders among the general population."
Mr. Ping Chen, Chief Executive Officer of Dehaier, stated, "We are pleased to take our relationship with the Air Force General Hospital to the next level. Leveraging the Hospital's strength in clinical research studies and patient care and Dehaier's focus on delivering innovative sleep respiratory solutions, the cooperation between the two parties is poised to tremendously benefit us a strong technical assistance and clinical data support in rapid delivering innovative wearable sleep respiratory solution systems to an ever-growing number of sleep apnea patients in China."
About the Air Force General Hospital
Established in October 1956, the Air Force General Hospital (the "Hospital") is a premier hospital in Beijing, China with over 1,000 beds and over 1,000 physicians and staff. The Hospital's Clinical Sleep Medicine Center, founded over thirty years ago, is one of the leading sleep disorder centers in China focused on providing comprehensive respiratory care and sleep disorder treatment with sleep specialists certified by the American Board of Sleep Medicine. More information may be found at http://www.kj-hospital.com.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and eleven software copyrights. More information may be found at http://www.dehaier.com.cn.
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.